March 22, 2020 marks World Water Day. On this day, we turn our thoughts to water, climate change, and the link between these two. For World Water Day, we are highlighting two blog posts featuring stories of scientists studying the oceans and marine life as well as images of microscopic marine animals from our social... Read more
Basel, 17 March 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its shareholders approved all proposals of the Board of Directors at its ordinary Annual General Meeting (AGM). On the basis of COVID-19 Ordinance 2 of the Swiss Federal Council, no shareholders were admitted to attend the General Meeting in person. Roche... Read more
Achieving Underwater Optical Wi-Fi Using Underwater DronesRelease of MC100 Underwater Optical Wireless Communication Modem Read more
Annual General Meeting on 17 March 2020 will take place as planned under conditions set by the authorities in Switzerland Roche strongly advises against physical participation and recommends electronic voting via the independent proxy Despite health measures participation will be at attendees’ own risk Basel, 14 March 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY)... Read more
Learn more about a few of our featured female scientists Today, March 8, 2020, marks International Women’s Day. ZEISS Research Microscopy applauds the many women scientists across the globe who are driving research forward. Read a few examples of women scientists profiled on our blog and how their efforts are contributing to advancement of many... Read more
28 February 2020 – Further to the announcement on 17 January, Spectris plc (SXS: LSE), the expert in providing insight through precision measurement, today announces that it has completed the sale of its interest in the EMS Brüel & Kjær joint venture to Envirosuite Limited. Contacts: Spectris plcSiobhán AndrewsHead of Corporate Affairs +44 1784 485325... Read more
20 February 2020 – Spectris plc (SXS: LSE), the expert in providing insight through precision measurement, announces full year results for the twelve months ended 31 December 2019. Executing our Strategy for Profitable Growth – Sales of £1,632.0 million, reflecting a 0.4% LFL sales increase – Adjusted operating profit increased 3.7%, on a LFL basis,... Read more
Hilden, Germany, and Germantown, Maryland, February 20, 2020 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that Nigeria, the country with the largest population in Africa and one of the world’s 30 high-disease burden countries for tuberculosis (TB), has published guidelines recommending QuantiFERON®-TB Gold Plus (QFT®-Plus) in screening for latent TB infection (LTBI)... Read more
This marks the first approval for a Tecentriq-based therapy in China, less than a year after the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals in this indication Tecentriq with chemotherapy (carboplatin and etoposide) is the first and only cancer immunotherapy combination approved for the initial treatment of extensive-stage small cell... Read more